Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation

Contraception

Volumn 84, Issue 2, 2011, Pages 128-132

  Huq, Farah Yasmine ^a   Tvarkova, Katerina ^a   Arafa, Aliaa ^a   Kadir, Rezan A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Contraception; Heavy menstrual bleeding; Menorrhagia; Oral anticoagulation; Warfarin

Indexed keywords

COPPER INTRAUTERINE DEVICE; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; WARFARIN;

ADULT; AFRICAN AMERICAN; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASIAN; BLEEDING; BUDD CHIARI SYNDROME; CAUCASIAN; DEEP VEIN THROMBOSIS; FEMALE; HORMONAL CONTRACEPTION; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION DISORDER; MITRAL VALVE STENOSIS; NEPHROTIC SYNDROME; ORAL CONTRACEPTION; PICTORIAL BLEEDING ASSESSMENT CHART; PORTAL VEIN THROMBOSIS; QUESTIONNAIRE; RATING SCALE; TREATMENT DURATION; VASCULITIS;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; CONTRACEPTION BEHAVIOR; FEMALE; HUMANS; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; WARFARIN; YOUNG ADULT;

EID: 79960325537     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.12.011     Document Type: Article

References (24)

1. Heinmann L.A.J., and Dinger J.C. Range of published estimates of venous thromboembolism incidence in young women Contraception 75 2007 328 336 (Pubitemid 46551070)
2. Vandenbroucke J.P., Rosing J., and Bloemenkamp K.W.M. Oral contraceptives and the risk of venous thrombosis N Eng J Med 344 2001 1527 1535 (Pubitemid 32429213)
3. Palareti G., Leali N., and Coccheri S. Bleeding complications of oral anticoagulation treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian study on the complications of oral anticoagulation therapy Lancet 348 1996 423 428 (Pubitemid 26267872)
4. Higham J., O'Brien P.M.S., and Shaw R.W. Assessment of menstrual blood loss using a pictorial chart BJOG 97 1990 734
5. Sjalander A., Friberg B., Svensson P., Stigendal L., and Lethagen S. Menorrhagia and minor bleeding symptoms in women on oral anticoagulation J Throm Thrombolysis 24 2007 39 41 (Pubitemid 46831562)
6. van Eijkeren M., Christiaens G., Haspels A., and Sixma J. Measured menstrual blood loss in women with a bleeding disorder using oral anticoagulation therapy Am J Obstet Gynecol 62 1990 1261 1263 (Pubitemid 20174052)
7. Lensing A.W.A., Prandoni P., Prins H.R., and Buller H.R. Deep vein thrombosis Lancet 353 1999 479 485
8. Ginsberg J.S. Management of venous thromboembolism N Eng J Med 335 1996 1816 1828 (Pubitemid 26412402)
9. Douketis J.D., Kearon C.B., Bates S., Duku E.K., and Ginsberg J.S. The risk of fatal pulmonary embolus in patients with treated venous thromboembolism JAMA 279 1998 458 462 (Pubitemid 28082257)
10. Thorogood M., Mann J., Murphy M., and Vessey M. Risk factors for fatal venous thromboembolism in young women: a case control study Int J Epidemiol 21 1992 48 52
11. WHO Venous thromboembolic disease and combined oral contraceptives: results of an international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Lancet 346 1995 1575 1582
12. Farmer R.D., Lawrenson R.A., Thompson C.R., Kennedy J.G., and Hambleton I.R. Population-based study of risk of venous thromboembolism associated with various oral contraceptives Lancet 349 1997 83 88 (Pubitemid 27023424)
13. van Hylckama Vlieg A., Helmerhorst F.M., Vandenbroucke J.P., Doggen C.J.M., and Rosendaal F.R. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progesterone type: results of the MEGA case-control study BMJ b2921 2009 339
14. World Health Organization. Medical Eligibility Criteria for Contraceptive Use (4th ed.); 2009 [cited 2010 June 10]. Available from: http://whqlibdoc.who. int/publications/2009/9789241563888-eng.pdf.
15. Haubacher D., Chen P.L., and Park S. Side effects of the copper IUD: do they decrease over time Contraception 79 2009 356 362
16. Trussell J. Contraceptive failure in the United States Contraception 70 2 2004 89 96 (Pubitemid 38993483)
17. Culwell K.R., and Curtis K.M. Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review Contraception 80 2009 337 345
18. Gomes M.P., and Deitcher S.R. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormonal replacement therapy Arch Intern Med 164 2004 1965 1976 (Pubitemid 39390552)
19. National Institute for Health and Clinical Excellence. Heavy menstrual bleeding: full guideline [CG44] 2007 National Institute for Health and Clinical Excellence London
20. Schaedel Z.E., Dolan G., and Powell M.C. The use of levonorgestrel releasing intrauterine system in the management of menorrhagia in women with haemostatic disorders Am J Obstet Gynecol 193 2005 1361 1363 (Pubitemid 41395104)
21. Sonmezer M., Atabekoglu C., and Cengiz B. Depot-medroxyprogesterone acetate in anticoagulated patients with previous haemorrhagic corpus luteum Eur J Contracept Reprod Health care 10 2005 9 14 (Pubitemid 40780750)
22. Wesley A.C., Neustader M.I., and Levine W. Massive intraperitoneal hemorrhage of ovarian follicular origin during anticoagulant therapy Am J Obstet Gynecol 73 1957 683 685
23. Cretel E., Cacoub P., Gompel A., Durand J.M., and Piette J.C. Haemoperitoneum of ovarian origin complicating antivitamin K treatment Rev Med Interne 21 5 2000 428 434
24. Rice C.F., Killick S.R., Dieben T., and Coelingh Bennink H. A comparison of the inhibition of ovulation achieved by desogestrel 75 mcg daily and levonorgestrel 30 mcg daily Hum Reprod 14 1999 982 985 (Pubitemid 29176478)